Jan 07,2022

Nemaura Medical to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference

Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces today that CEO Dr. Faz Chowdhury will present a corporate overview at the H.C. Wainwright Bioconnect 2022 Virtual Conference, which is taking place on January 10 – 13, 2022.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Jan 11,2022

Nemaura Medical Appoints Dr Arash Ghadar as Chief Operating Officer

Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces the appointment of Dr Arash (Ash) Ghadar as Chief Operating Officer.

View Analyst & Ambassador Comments
Go to original news
Jan 11,2022

BD Named One of America's Most Just Companies in Annual JUST 100 Ranking

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it was named to the JUST 100 list of America's most just companies by JUST Capital and its media partner CNBC.

View Analyst & Ambassador Comments
Go to original news
Jan 12,2022

Glytec and Roche Announce Strategic Partnership to Bring Digital Health Innovation in Glycemic Decision Support to the Hospital Bedside

This digital health collaboration combines Roche’s expertise in medical devices and IT solutions with Glytec’s FDA-cleared insulin dosing decision support software, Glucommander™, to address the pervasive challenges with inpatient blood sugar management at the hospital bedside.

COLLABORATION PARTNERSHIP

#product & service

View Analyst & Ambassador Comments
Go to original news
Jan 13,2022

Marpai’s AI-Powered Health Predictions Gain Traction with URAC Accredited Care Management

Marpai, Inc., a deep learning technology company transforming the $1T+ self-funded health insurance market with AI-powered services, launches Marpai Cares, its premier AI-powered proactive health service. Using proprietary, predictive deep learning models, Marpai identifies near-term health events related to chronic illness (including cardiovascular disease, diabetes, and COPD) and major procedures (such as knee surgery) to enable member actions that can prevent costly claims.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Jan 14,2022

Glytec garners cybersecurity certification for insulin management system

Glytec announced today that its eGlycemic Management System received certified status for information security from HITRUST.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Jan 17,2022

Brighter extends the agreement with Erik Lissner as acting CEO with an agreement of permanent employment from June 16

Brighter AB (Publ) announced today that its Board of Directors will extend the agreement with Erik Lissner as Acting CEO of Brighter until 15 June 2022 and that an agreement on permanent employment will commence thereafter.

View Analyst & Ambassador Comments
Go to original news
Jan 18,2022

DarioHealth to Host Investor Webinar on Navigating Emerging Digital Health Trends for Strategic Growth in 2022

Webinar to be held Wednesday, January 19th at 8am ET

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Jan 18,2022

Acting CFO Christopher Robinson takes permanent role as CFO of Brighter

Brighter AB announces today that Christopher Robinson will assume the role of Chief Financial Officer (CFO) at Brighter after having the position as acting since 16 August 2021.

View Analyst & Ambassador Comments
Go to original news
Jan 19,2022

DarioHealth Enters into Agreement with Large Regional Health Plan

DarioHealth Corp. (NASDAQ-CM: DRIO), a leader in the global digital therapeutics (DTx) market, announced today it has contracted with a large regional health plan (the "Plan") to deliver its digital therapeutic solution for diabetes for eligible Medicaid members in and around the mid-Atlantic region.

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES